This opportunity is no longer accepting applications.
grant NIH/NCI 473

Point of Care Detection of Antibodies Against HPV16/18 E6 and E7 Oncoproteins in Oropharyngeal Cancer

This grant seeks proposals for research aimed at improving early detection of HPV-related oropharyngeal cancer (OPC), a type of cancer linked to HPV infections, particularly HPV16 and HPV18. Current HPV vaccines help prevent related cancers, but there is a lack of effective screening for early detection of OPC. The focus is on identifying antibodies against HPV E proteins (specifically E6 and …

Fast-Track proposals will be accepted.\nDirect-to-Phase II proposals will NOT be accepted.\nNumber of anticipated awards: 2-4\nBudget (total costs, per award):\nPhase I: up to $400,000 for up to 12 months\nPhase II: up to $2,250,000 for up to 2 years\nPROPOSALS THAT EXCEED THE BUDGET OR PROJECT …

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: August 2, 2024
Open for Submission: August 2, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.